Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
5.51
-0.02 (-0.36%)
At close: Mar 6, 2026, 4:00 PM EST
5.40
-0.11 (-2.00%)
After-hours: Mar 6, 2026, 7:42 PM EST
Compass Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
35
Market Cap
992.28M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Pharming Group | 362.27M |
| Xeris Biopharma Holdings | 291.85M |
| Geron | 183.88M |
| UroGen Pharma | 109.79M |
| AbCellera Biologics | 75.13M |
| Aktis Oncology | 5.56M |
| Inhibrx Biosciences | 1.40M |
CMPX News
- 2 days ago - Compass Therapeutics Reports 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 6 weeks ago - Compass Therapeutics: Exciting Clinical Updates Inbound For 2026 - Seeking Alpha
- 7 weeks ago - Compass Therapeutics, Inc. (CMPX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 2 months ago - Compass Therapeutics Provides Corporate Update - GlobeNewsWire
- 2 months ago - Compass Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - Compass Therapeutics Announces Key Leadership Appointments - GlobeNewsWire
- 2 months ago - Compass Therapeutics to Participate in the J.P. Morgan 2026 Healthcare Conference - GlobeNewsWire
- 3 months ago - Compass Therapeutics, Inc. (CMPX) Presents at Evercore 8th Annual Healthcare Conference Transcript - Seeking Alpha